Announcement on behalf of Amaran Biotechnology, Inc., a major subsidiary, that the Company’s Board of Directors resolved to revise the Regulations for Issuance and Subscription of 2020 Employee Stock Options

1.Date of the Board of Directors resolution: September 9, 2021 2.Issue period: Pursuant to Article 167-2 of the Company Act, issued at once or in tranches within 2 years from the date of approval of Board of Directors. The Chairman is authorized to determine the actual issue date. 3.Eligibility criteria for optionees: (1)Restricted to full-time […]